In conclusion, we have demonstrated that BRG1 is expressed in a range of T-cell lymphomas and its protein levels are maintained by NPM-ALK activity in ALK+ ALCL cell lines. Here, SMARCA4 is linked to T-cell non-Hodgkin lymphoma.